General Information of Drug Off-Target (DOT) (ID: OTDESHKT)

DOT Name Tryptase gamma (TPSG1)
Synonyms EC 3.4.21.-; Serine protease 31; Transmembrane tryptase
Gene Name TPSG1
Related Disease
Cognitive impairment ( )
Obsessive compulsive disorder ( )
Osteochondritis dissecans ( )
Parkinson disease ( )
Schizophrenia ( )
Type-1/2 diabetes ( )
Alzheimer disease ( )
Amyloidosis ( )
Attention deficit hyperactivity disorder ( )
Behavioral variant of frontotemporal dementia ( )
Bipolar disorder ( )
Brain cancer ( )
Brain neoplasm ( )
Breast carcinoma ( )
Breast neoplasm ( )
Cerebrovascular disease ( )
Chronic obstructive pulmonary disease ( )
Colitis ( )
Dementia ( )
Linear nevus sebaceous syndrome ( )
Frontal lobe epilepsy ( )
Anxiety disorder ( )
Depression ( )
Lewy body dementia ( )
UniProt ID
TRYG1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.4.21.-
Pfam ID
PF00089
Sequence
MALGACGLLLLLAVPGVSLRTLQPGCGRPQVSDAGGRIVGGHAAPAGAWPWQASLRLRRV
HVCGGSLLSPQWVLTAAHCFSGSLNSSDYQVHLGELEITLSPHFSTVRQIILHSSPSGQP
GTSGDIALVELSVPVTLSSRILPVCLPEASDDFCPGIRCWVTGWGYTREGEPLPPPYSLR
EVKVSVVDTETCRRDYPGPGGSILQPDMLCARGPGDACQDDSGGPLVCQVNGAWVQAGTV
SWGEGCGRPNRPGVYTRVPAYVNWIRRHITASGGSESGYPRLPLLAGFFLPGLFLLLVSC
VLLAKCLLHPSADGTPFPAPD
Tissue Specificity Expressed in many tissues.

Molecular Interaction Atlas (MIA) of This DOT

24 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cognitive impairment DISH2ERD Definitive Biomarker [1]
Obsessive compulsive disorder DIS1ZMM2 Definitive Genetic Variation [2]
Osteochondritis dissecans DIS1FGN4 Definitive Genetic Variation [2]
Parkinson disease DISQVHKL Definitive Genetic Variation [3]
Schizophrenia DISSRV2N Definitive Biomarker [2]
Type-1/2 diabetes DISIUHAP Definitive Biomarker [1]
Alzheimer disease DISF8S70 Strong Biomarker [4]
Amyloidosis DISHTAI2 Strong Genetic Variation [5]
Attention deficit hyperactivity disorder DISL8MX9 Strong Biomarker [6]
Behavioral variant of frontotemporal dementia DISQHX2V Strong Biomarker [7]
Bipolar disorder DISAM7J2 Strong Genetic Variation [8]
Brain cancer DISBKFB7 Strong Genetic Variation [9]
Brain neoplasm DISY3EKS Strong Genetic Variation [9]
Breast carcinoma DIS2UE88 Strong Biomarker [10]
Breast neoplasm DISNGJLM Strong Biomarker [11]
Cerebrovascular disease DISAB237 Strong Biomarker [12]
Chronic obstructive pulmonary disease DISQCIRF Strong Biomarker [13]
Colitis DISAF7DD Strong Biomarker [13]
Dementia DISXL1WY Strong Biomarker [14]
Linear nevus sebaceous syndrome DIS6VQ2J Strong Biomarker [10]
Frontal lobe epilepsy DISHN8AO moderate Biomarker [15]
Anxiety disorder DISBI2BT Limited Genetic Variation [16]
Depression DIS3XJ69 Limited Biomarker [17]
Lewy body dementia DISAE66J Limited Biomarker [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 24 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Tryptase gamma (TPSG1). [19]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Tryptase gamma (TPSG1). [24]
------------------------------------------------------------------------------------
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Tryptase gamma (TPSG1). [20]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Tryptase gamma (TPSG1). [21]
Triclosan DMZUR4N Approved Triclosan increases the expression of Tryptase gamma (TPSG1). [22]
Azacitidine DMTA5OE Approved Azacitidine decreases the expression of Tryptase gamma (TPSG1). [23]
------------------------------------------------------------------------------------

References

1 RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.PLoS One. 2016 Jan 8;11(1):e0145521. doi: 10.1371/journal.pone.0145521. eCollection 2016.
2 Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder.Schizophr Res. 2018 Nov;201:151-158. doi: 10.1016/j.schres.2018.05.029. Epub 2018 May 29.
3 Effects of Transcranial Direct Current Stimulation (tDCS) Over the Frontal Polar Area on Motor and Executive Functions in Parkinson's Disease; A Pilot Study.Front Aging Neurosci. 2018 Jul 30;10:231. doi: 10.3389/fnagi.2018.00231. eCollection 2018.
4 Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial.J Alzheimers Dis. 2019;72(4):1209-1216. doi: 10.3233/JAD-190757.
5 Amyloid-, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.Front Aging Neurosci. 2018 Jun 25;10:193. doi: 10.3389/fnagi.2018.00193. eCollection 2018.
6 Executive Function Training for Children with Attention Deficit Hyperactivity Disorder.Chin Med J (Engl). 2017 Mar 5;130(5):549-558. doi: 10.4103/0366-6999.200541.
7 Reduced tendency to attribute mental states to abstract shapes in behavioral variant frontotemporal dementia links with cerebellar structural integrity.Neuroimage Clin. 2019;22:101770. doi: 10.1016/j.nicl.2019.101770. Epub 2019 Mar 12.
8 Tryptophan breakdown and cognition in bipolar disorder.Psychoneuroendocrinology. 2017 Jul;81:144-150. doi: 10.1016/j.psyneuen.2017.04.015. Epub 2017 Apr 27.
9 Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.Lancet Oncol. 2019 Oct;20(10):1444-1453. doi: 10.1016/S1470-2045(19)30502-9. Epub 2019 Sep 2.
10 Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF.Int J Cancer. 2002 Jul 1;100(1):2-8. doi: 10.1002/ijc.10481.
11 Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling.J Proteome Res. 2017 Mar 3;16(3):1121-1132. doi: 10.1021/acs.jproteome.6b00374. Epub 2017 Feb 3.
12 Small Vessel Disease on Neuroimaging in a 75-Year-Old Cohort (PIVUS): Comparison With Cognitive and Executive Tests.Front Aging Neurosci. 2018 Jul 16;10:217. doi: 10.3389/fnagi.2018.00217. eCollection 2018.
13 Importance of mast cell Prss31/transmembrane tryptase/tryptase- in lung function and experimental chronic obstructive pulmonary disease and colitis.J Biol Chem. 2014 Jun 27;289(26):18214-27. doi: 10.1074/jbc.M114.548594. Epub 2014 May 12.
14 Errors versus speed on the trail making test: Relevance to driving performance.Accid Anal Prev. 2018 Apr;113:125-130. doi: 10.1016/j.aap.2018.01.004. Epub 2018 Mar 7.
15 Emotional asymmetries in refractory medial temporal and frontal lobe epilepsy: Their impact on predicting lateralization and localization of seizures.Epilepsy Behav. 2019 May;94:269-276. doi: 10.1016/j.yebeh.2019.03.008. Epub 2019 Apr 11.
16 Comparison of Neurological and Cognitive Deficits in Children With ADHD and Anxiety Disorders.J Atten Disord. 2018 Mar;22(5):472-485. doi: 10.1177/1087054715578003. Epub 2015 Jun 15.
17 Effects of MitraClip on cognitive and psychological function in heart failure patients: the sicker the better.Eur J Med Res. 2019 Feb 22;24(1):14. doi: 10.1186/s40001-019-0371-z.
18 A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer's Disease.Front Neurol. 2018 Mar 6;9:124. doi: 10.3389/fneur.2018.00124. eCollection 2018.
19 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
20 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
21 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
22 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
23 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
24 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.